Noel D'Angelo is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating cancer. With a total of 11 patents to his name, D'Angelo's work has the potential to impact the lives of many patients.

Latest Patents

D'Angelo's latest patents include groundbreaking inventions such as "Inhibitors of PI3 kinase and/or mTOR." This invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, and methods of treating diseases or conditions, such as cancer, using these compounds. Additionally, he has developed a "Method of treating cancer with substituted amide derivatives," which encompasses novel compounds, analogs, prodrugs, and pharmaceutical compositions for the prophylaxis and treatment of diseases, including HGF mediated diseases.

Career Highlights

Throughout his career, D'Angelo has worked with notable companies, including Amgen Inc. and Amgen Inc. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in medical research and drug development.

Collaborations

D'Angelo has collaborated with talented individuals such as Shon Booker and Tae-Seong Kim. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Noel D'Angelo's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving healthcare. His work continues to pave the way for new treatments and therapies that can benefit countless individuals.